An Industry-Driven Roadmap for Manufacturing in Regenerative Medicine

Area of Science:

• Regenerative Medicine
• Biotechnology
• Clinical Manufacturing

Background:

• Regenerative medicine is a rapidly growing field with significant future potential.
• Standardized and automated clinical manufacturing is crucial for its advancement.
• Industry investment necessitates a clear path toward large-scale production.

Purpose of the Study:

• To develop an industry-driven roadmap for regenerative medicine clinical manufacturing.
• To identify critical roadblocks hindering large-scale manufacturing.
• To establish a consensus on the optimal pathway for therapy access.

Main Methods:

• A 3-year collaborative effort by a consortium of invested companies.
• Identification of critical roadblocks through stakeholder consensus.
• Development of a strategic roadmap for industrial-scale manufacturing.

Main Results:

• A comprehensive roadmap for industrial-scale regenerative medicine manufacturing was created.
• Key challenges impeding large-scale clinical production were identified.
• A consensus was reached on accelerating patient access to therapies.

Conclusions:

• Standardized and automated manufacturing is essential for the regenerative medicine industry.
• Addressing identified roadblocks is critical for scaling up production.
• Collaborative industry efforts can expedite global access to regenerative medicine therapies.